Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures The CORE-VNS 36-month data analysis reaffirms the effectiveness of VNS Therapy ...
A novel therapy involving electrical pulses to the vagus nerve might unlock the brain’s hidden potential to rewire itself, and heal where words and pills fall short. Initially described as early as ...
Finding the right vagus nerve stimulation device can be tricky; TPIMS reviewed dozens and found the most effective options ...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present eight posters at the American Epilepsy Society (AES) Annual Meeting, taking place Dec. 5-9 in ...
Shares of LivaNova (NASDAQ:LIVN) fell 11% in late morning trading Thursday after the company reported that the unipolar patient cohort of its RECOVER study for its VNS Therapy product for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback